Sulfuric Acid

Sulfuric Acid

SCHEMBL3863244

CCCCCCCCOc1cccc(I)c1-c1ccccc1.CCCCCCCCOc1cccc(I)c1-c1ccccc1.FC(F)(F)F.O=S(=O)(O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CALCRLCHRM1CHRM2CHRM3F2RMAOAMAOBMAP2K1MAP2K2NTRK1NTRK2NTRK3OPRD1OPRK1OPRM1P2RY12PKLRSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASLC18A2SLC6A2SLC6A3TLR7TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8dacAdacBdacCfolAftsImrcAmrcBmrdApolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmB1rpmB2rpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmHrpmIrpmJrpmJ2rpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsR1rpsR2rpsSrpsTrpsUrpsZykgMykgO

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.42
ADRA2A known ✓ P08913 1/20 0.42
OPRK1 known ✓ P41145 1/20 0.42
SLC6A3 known ✓ Q01959 1/20 0.42
PTPN11 Q06124 4/20 0.44
MEN1 O00255 1/20 0.42
NR1I2 O75469 1/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
HTR2B P41595 1/20 0.42
KMT2A Q03164 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
PTPN1 P18031 3/20 0.41
S1PR3 Q99500 1/20 0.40
THRA P10827 2/20 0.40
THRB P10828 2/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.39
CNR2 P34972 1/20 0.39
CYSLTR2 Q9NS75 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perflubutane SCHEMBL3873214 0.94 PTPN11 (0.42) PTPN11MEN1NR1I2LMNACHRM2
Trifluoromethanesulfonic Acid SCHEMBL8736419 0.94 PTPN11 (0.43) PTPN11MEN1NR1I2LMNACHRM2
Trifluoromethanesulfonic Acid SCHEMBL8736534 0.89 RXFP1 (0.42) PTPN11MEN1NR1I2LMNACHRM2
SCHEMBL3869746 0.88 PTPN11 (0.47) PTPN11MEN1NR1I2LMNACHRM2
SCHEMBL27963565 0.82 CYP1A2 (0.49) PTPN11KDM4E
Trifluoromethanesulfonic Acid SCHEMBL8735162 0.80 KCNA3 (0.34) MEN1LMNAKMT2AHDAC6PTPN1
SCHEMBL7892669 0.80 S1PR3 (0.41) PTPN11MEN1LMNAMAPTKMT2A
Perflubutane SCHEMBL3873217 0.77 PTGDR2 (0.43) PTPN11MEN1NR1I2LMNACHRM2
Trifluoromethanesulfonic Acid SCHEMBL8736420 0.76 PTGDR2 (0.45) PTPN11MEN1NR1I2LMNACHRM2
Trifluoromethanesulfonic Acid SCHEMBL8737229 0.75 BID (0.43) MAPTCYSLTR2CYSLTR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601480-B2 Photoactive compounds AZ ELECTRONIC MATERIALS USA CORP. (US) 2009-10-13 US disclosed
US-20080153032-A1 Photoactive Compounds MERCK PATENT GMBH (DE) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153032-A1 Photoactive Compounds SUN2, CRY2, SCO2 CHRM2 2335/4885ADRA2A 4680/4885OPRK1 4121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.